The President’s medical team started him on the steroid dexamethasone yesterday. Of the COVID therapeutics I’ve discussed this weekend, dex is the only one shown to reduce mortality in patients w/ severe COVID-19. But it can also be risky for patients with mild illness. 1/7
Data published earlier this year showed that dex reduced deaths by one-third in COVID patients who had been sick >7 days and were on mechanical ventilators. Among patients receiving oxygen by less invasive means it reduced deaths by one-fifth. 2/7
However, here’s a key point: patients given dex who weren't on respiratory support died at a *higher* rate than similar pts who didn’t get dex. This wasn’t statistically significant, but if there’s no benefit & may be harmful, this is not a drug you start w/out good reason. 3/7
Taken together, all of this suggests that Trump’s medical team is treating him as if he has severe COVID-19. 4/7
Trump’s docs say he could be discharged as soon as Mon. This strikes me as misleading - if I were treating a patient hospitalized with COVID and they had just been started on dexamethasone for multiple desats, I certainly wouldn’t tell them to expect discharge in 24 hrs. 5/7
Trump is now on the major drugs we have to support patients as they battle COVID. One add'l option his docs may reach for is convalescent plasma, but this is still poorly understood and not routinely used outside clinical trials (despite Trump touting it as a breakthrough). 6/7
It will be several more days before we know if the President is in the clear. Next concerning steps to watch for would be escalation of respiratory support: oxygen by nasal cannula → high flow nasal cannula → intubation. Hope it doesn't come to that. 7/7
• • •
Missing some Tweet in this thread? You can try to
force a refresh
Americans are getting a crash course in novel therapies for #COVID19. This is a hotly debated topic, even among physicians. As we saw with hydroxychloroquine, the decisions Trump/his docs make affect what patients expect in their own care, so it’s worth talking about remdesivir.
Remdesivir is an antiviral originally developed to treat hepatitis C and later tried as a treatment for Ebola & Marburg. It didn’t work against those viruses, but it appears to have an effect on coronavirus (a good reminder that research on rare viruses can benefit us all)
2/n
Initial data from clinical trials were promising enough that the FDA granted emergency use authorization on May 1 for use in severely ill COVID-19 patients. In August FDA expanded this to apply to any hospitalized patient (the category Trump apparently falls under).
3/n
Earlier today President Trump received a polyclonal antibody cocktail made by the company Regeneron. Here’s what we know about this drug, and the additional drugs a patient in his situation might receive in the coming days.
Thread.
The cocktail is a combo of 2 lab-generated antibodies. The goal here is to boost an individual’s immune system rather than waiting for the body’s response to kick in on its own. When given early in the course of infection, this can theoretically shorten the length of illness 2/n
No peer-reviewed studies have examined whether Regeneron’s cocktail is safe or effective. Just 3 days ago the company announced (but did not publish) preliminary data from its ongoing trial. 3/n
.@gatesfoundation's Goalkeepers report is the blueprint for an effective global health response that the US & allies should have set in motion months ago. It's a clear-eyed assessment of where we stand & what we need to do. Quick highlight thread (1/x): gatesfoundation.org/goalkeepers/re…
First, where we stand: “We’ve been set back about 25 years in about 25 weeks.” This sobering assessment sums up the tragic fact that because of COVID, we risk losing gains made in reducing poverty, hunger, maternal mortality, HIV infections, & virtually every SDG indicator (2/x)
The report's modeling shows how much of a hit development has taken in just 6 months. But it also shows we can get back on track – if the US and other donors recommit to the trailblazing programs that have already saved millions of lives & led countless more out of poverty. (3/x)
We now know a bit more about the safety event that led @AstraZeneca’s COVID vaccine trial to be put on hold. The trial has since resumed, but the event (and the way it was handled) has important implications for how we develop a safe, widely trusted coronavirus vaccine.
Thread
First, as many have noted, the fact that a clinical hold was placed is a sign that the regulatory process is still working, despite considerable political pressure to rush a vaccine. Clinical holds are not uncommon, even for products that ultimately prove safe & effective. (2/10)
That said, this event shows why Phase 3 trials are essential. As @adamfeuerstein from STAT news first reported, the clinical hold was placed because a participant who received the vaccine developed symptoms consistent with transverse myelitis. (3/10)
7 of every 10 new COVID-19 cases are now in red states. While the early pandemic mostly affected blue states because of travel and demographic characteristics, Trump’s denial of basic science is to blame for most of these new cases (and the deaths that will surely follow)
Views on mask use and other basic public health interventions are now driven by politics. Shockingly, even America’s massive death toll is a partisan issue. More than half of Republicans say the number of fatalities from COVID-19 is “acceptable” (2/6)
186,000 Americans have lost their lives to COVID-19. That's as many U.S. deaths in 9 months as lung & colorectal cancer claim in an entire year. By the end of the year this figure could reach 300,000. That’s more than all the U.S. servicemember battle deaths in WWII. (3/6)